Civic AI
Procurement intelligence
Federal contract award
FURTHER CHARACTERIZATION AND VALIDATION OF MONOCLONAL ANTIBODIES TO STUDY RESPIRATORY
AMPERSAND BIOSCIENCES LLC · Department of Health and Human Services
- Value
- $1,084,824
- Start
- Sep 30, 2024
- End
- Sep 29, 2026
- Action date
- Apr 9, 2026
- PIID
- 75N93024C00087
- Status
- active
- NAICS
- 541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
- Place of performance
- LAKE CLEAR, NY
- Award type
- DEFINITIVE CONTRACT
Description
FURTHER CHARACTERIZATION AND VALIDATION OF MONOCLONAL ANTIBODIES TO STUDY RESPIRATORY
Need modifications, related awards, and vendor peers? Open the full award workspace.